Screener
Rapport Therapeutics, Inc. RAPP Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 7:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333862
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Total assets | $458,982 | $512,431 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable | $2,796 | $4,190 |
| Accrued expenses and other current liabilities | 23,155 | 12,104 |
| Operating lease liability | 2,473 | 2,755 |
| Total current liabilities | 28,424 | 19,049 |
| Operating lease liability, net of current portion | 7,632 | 8,729 |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s accounts payable?
- Rapport Therapeutics, Inc. (RAPP) reported accounts payable of $2.8M in Q2 2026.
- How has Rapport Therapeutics, Inc.'s accounts payable changed year-over-year?
- Rapport Therapeutics, Inc.'s accounts payable decreased by 12.0% year-over-year, from $3.18M to $2.8M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Rapport Therapeutics, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude